Society for Neuroscience - Search

Skip Navigation

  • join logo Join
  • hands shaped like a yellow heart icon Give
  • advocate logo Advocate
  • publish logo Publish
  • Icon with thought bubbles Learn
Shop Sign In
SfN Logo 2025
  • Membership
    • Learn About Membership
      • Individual Member Benefits
      • Institutional Program Member Benefits
      • Sustaining Associate Member Benefits
      • Get Involved at SfN
    • Become a Member
      • Sponsorship Information for New Members
      • Membership Categories & Fees
      • Membership Fees for Developing Countries
      • Renew Individual Membership
    • Member Resources
      • Automatic Renewals
      • Frequently Asked Questions
      • Individual Member Directory
      • Member Obituaries and Memorial Donations
    • Learn About Local Chapters
      • Start or Reactivate a Chapter
      • Resources for Chapters
      • Submit Annual Report
      • Chapter Directory
      • Frequently Asked Questions
  • Meetings
    • Meetings Overview
    • Neuroscience 2025
      • Presenter Resources
      • Itinerary Planner and Mobile App
      • Virtual Component
      • Sessions and Events
      • Registration
      • Housing and Travel
      • Exhibits
      • FAQs
    • Global Events
      • SfN Virtual Events
    • Past and Future Annual Meetings
      • Neuroscience 2024
      • Neuroscience 2023
      • Search Past Annual Meeting Abstracts
      • Attendance Statistics
    • Meeting Policies and Guidelines
      • Code of Conduct at SfN Events
      • Growth and Opportunity Strategy
      • Photography & Recording Policy
      • Presenter Guidelines and Policies for SfN Events
    • Meeting Awards
      • Trainee Professional Development Award
      • International Travel Awards
      • FENS Member Awards to SfN Annual Meeting
      • IBRO Member Awards to SfN Annual Meeting
      • JNS Member Awards to SfN Annual Meeting
  • Careers
    • Careers Overview
    • Institutional Program (IP) Directory
    • NeuroJobs Career Center
      • Job Seekers
      • Employers
    • 2025 Graduate School Fair
    • Career Tools and Resources
      • Neuronline
      • Neurobiology of Disease Workshop
      • Responsible Conduct of Research Short Courses
      • Neuroscience Departments and Program Workshop
      • Global Funding Sources
    • Higher Education and Training
      • Core Competencies
      • Neuroscience Training Program Survey
    • Awards
      • Outstanding Career and Research Achievements
      • Early Career
  • Initiatives
    • Initiatives Overview
    • Awards
      • 2025 Award Recipients
      • Awards and Prizes FAQ
      • Trainee Professional Development Award
    • Neuroscience Scholars Program
    • Neuronline
      • Webinars
      • Articles
      • Videos
      • Podcasts
      • Collections
    • Resources to Stay Connected
      • SfN Zoom Backgrounds
    • Community
    • Women and Neuroscience
      • Increasing Women in Neuroscience (IWiN) Courses & Toolkit
      • Celebration of Women in Neuroscience Event
      • Awards
    • Animals in Research
      • Support for Members and Institutions
      • Tools and Resources
      • Resources for Medical Students
    • Public Education Programs
      • Resources for Educators
      • Brain Awareness Video Contest
      • Life of a Neuron Exhibit
  • Advocacy
    • Advocacy Overview
    • Advocacy Response
    • Advocacy Network
      • The NeuroAdvocate Challenge
      • Advocacy Action Center
      • Advocacy Best Practices
      • Advocacy Network News
      • Advocacy Training Seminars
    • US Advocacy Programs
      • Capitol Hill Day
      • Connect with Policymakers
      • Early Career Policy Ambassadors
      • Partner with a Local Chapter
      • Engage the Media
    • Global Advocacy Programs
      • Global Neuroscience Initiatives
      • Global Funding
      • North American Programs
    • Science Funding
      • Advocacy Videos
      • Advocacy Resources
      • US Neuroscience Initiatives
      • Funding Priorities and Processes
    • Policy Positions
      • Statements and Testimony
      • Sign-On Letters
  • Outreach
    • Outreach Overview
    • BrainFacts.org
    • Find a Neuroscientist
    • Brain Awareness Campaign
      • Webinar: The ABC's of BAW
      • How to Get Involved
    • Awards
      • Award for Education in Neuroscience
      • Next Generation Award
      • Chapter of the Year Award
      • Science Educator Award
  • Publications
    • Publications Overview
    • SfN News
    • JNeurosci
    • eNeuro
    • SfN Nexus
    • Neuroscience Quarterly
    • Annual Report
    • History of Neuroscience Autobiographical Chapters
  • About
    • About Overview
    • Mission and Strategic Plan
    • What We Do
      • Annual Report
      • Bylaws
      • Resolutions to the Bylaws
      • Environmental Commitment
      • Strategic Partners
      • History of SfN
    • SfN 50th Anniversary Celebration
    • NIH Public Health Service-Supported Funding Financial Conflict of Interest Policy
    • Volunteer
      • SfN Council
      • SfN Presidents
      • Committees
      • Elections
      • Call for Nominations
    • Professional Conduct
      • SfN Ethics Policy
      • Guidelines for Responsible Conduct Regarding Scientific Communication
      • Code of Conduct at SfN Events
      • Commitment to Scientific Integrity
      • Neuronline Digital Learning Community Guidelines
    • History of Neuroscience
      • Autobiographical Chapters
      • Autobiographical Videos of Prominent Neuroscientists
      • Classic Papers
      • Neuroscience History Resources
      • Robert Doty's Chapter on Neuroscience
    • Careers and Staff
      • Staff List
  1. Search

Filter

  • (2)
  • (1)
  • (3)
  • (6)
  • (8)
  • (1)
  • (574)
  • (3)
  • (2)
  • (8)
Filter
481 - 490 of 892 results
  • Nonpsychotropic Cannabinoid Receptors Regulate Microglial Cell Migration | Journal of Neuroscience
    During neuroinflammation, activated microglial cells migrate toward dying neurons, where they exacerbate local cell damage. The signaling molecules that trigger microglial cell migration are poorly understood. In this paper, we show that pathological overstimulation of neurons by glutamate plus carbachol dramatically increases the production of the endocannabinoid 2-arachidonylglycerol (2-AG) but only slightly increases the production of anandamide and does not affect the production of two putative endocannabinoids, homo-γ-linolenylethanolamide and docosatetraenylethanolamide. We further show that pathological stimulation of microglial cells with ATP also increases the production of 2-AG without affecting the amount of other endocannabinoids. Using a Boyden chamber assay, we provide evidence that 2-AG triggers microglial cell migration. This effect of 2-AG occurs through CB2 and abnormal-cannabidiol-sensitive receptors, with subsequent activation of the extracellular signal-regulated kinase 1/2 signal tran...
    Feb 15, 2003 Lisa Walter
  • Abstract
    Behavioral effects of CB2 cannabinoid receptor activation and its influence on food and alcohol consumption
    Consumers of marijuana feel a strong compulsive desire to consume food. The role of CB2 receptors in food and alcohol consumption and the behavioral effects of CB2 receptor ligands are not well understood. We tested the effects of CB2 agonist PEA and CB...
    Nov 7, 2007
  • Abstract
    Aging, circadian rhythms, and cannabinoids
    Hormetic dose-response relationships suggest that opposing physiological responses can be driven by a single substance, however, detection and quantification of hormetic relationships is often difficult. One potential therapeutic application of hormesis...
    Oct 20, 2019
  • The Endogenous Cannabinoid 2-Arachidonoylglycerol Is Intravenously Self-Administered by Squirrel Monkeys | Journal of Neuroscience
    Two endogenous ligands for cannabinoid CB1 receptors, anandamide ( N -arachidonoylethanolamine) and 2-arachidonoylglycerol (2-AG), have been identified and characterized. 2-AG is the most prevalent endogenous cannabinoid ligand in the brain, and electrophysiological studies suggest 2-AG, rather than anandamide, is the true natural ligand for cannabinoid receptors and the key endocannabinoid involved in retrograde signaling in the brain. Here, we evaluated intravenously administered 2-AG for reinforcing effects in nonhuman primates. Squirrel monkeys that previously self-administered anandamide or nicotine under a fixed-ratio schedule with a 60 s timeout after each injection had their self-administration behavior extinguished by vehicle substitution and were then given the opportunity to self-administer 2-AG. Intravenous 2-AG was a very effective reinforcer of drug-taking behavior, maintaining higher numbers of self-administered injections per session and higher rates of responding than vehicle across a wide...
    May 11, 2011 Zuzana Justinová
  • Bimodal Control of Fear-Coping Strategies by CB1 Cannabinoid Receptors | Journal of Neuroscience
    To maximize their chances of survival, animals need to rapidly and efficiently respond to aversive situations. These responses can be classified as active or passive and depend on the specific nature of threats, but also on individual fear coping styles. In this study, we show that the control of excitatory and inhibitory brain neurons by type-1 cannabinoid (CB1) receptors is a key determinant of fear coping strategies in mice. In classical fear conditioning, a switch between initially predominant passive fear responses (freezing) and active behaviors (escape attempts and risk assessment) develops over time. Constitutive genetic deletion of CB1 receptors in CB1 −/− mice disrupted this pattern by favoring passive responses. This phenotype can be ascribed to endocannabinoid control of excitatory neurons, because it was reproduced in conditional mutant mice lacking CB1 receptors from cortical glutamatergic neurons. CB1 receptor deletion from GABAergic brain neurons led to the opposite phenotype, characterized...
    May 23, 2012 Mathilde Metna-Laurent
  • Abstract
    Optogenetic dissection of dopamine-related neural mechanisms underlying cannabis reward versus aversion
    Cannabinoids can exert both hedonic and aversive effects. While some human users report euphoria following cannabis use, others report anxiety, and animal studies suggest cannabis is minimally reinforcing or dysphoric. However, the neural mechanisms und...
    Oct 23, 2019
  • Abstract
    Fluctations of extracellular dopamine levels in the shell portion of the rat nucleus accumbens during cannabinoid self-administration.
    Several evidence suggests that cannabinoids act upon the brain reward circuitry, namely the mesolimbic dopamine (DA) pathway, influencing drug-seeking and drug-taking behaviors in a manner strikingly similar to that of other abused drugs. Passive administrations of Δ9-tetrahydrocannabinol (THC) and synthetic CB1 receptor agonist WIN 55,212-2 are reported to enahance extracellular DA overflow in the nucleus accumbens and other reward-related forebrain areas, as measured by in vivo brain microdialysis. Few years ago we characterized a reliable model of cannabinoid intravenous self-administration (IVSA) in rats, in which animals were trained to self-administer the cannabinoid CB1 receptor agonist WIN 55,212-2 (12.5 μg/kg inf) under a fixed ratio (FR1) schedule of reinforcement (Fattore et al. 2001). In the present study we used this model to investigate the effect of active cannabinoid administration on the DA extracellular accumbal concentrations during cannabinoid IVSA. DA levels were measured in perfusate ...
    Nov 14, 2005
  • Abstract
    Initial characterization of a novel cannabinoid receptor in glial cells.
    Several studies have demonstrated that cannabinoids may induce specific biological effects by interacting with an orphan G protein-coupled receptor. Recently, it has been suggested that GPR55 might constitute such a receptor. Indeed, we found that THC (5 µM) increased intracellular calcium in HEK293 cells expressing GPR55. GPR55 mRNA was present in spleen, microglial cells and astrocytes, as well as BV2 and N9 cells (two mouse microglia cell lines), suggesting its involvement in regulating neuroinflammation. On the other hand, GPR55 mRNA was not detected in OLN cells, an oligodendrocyte progenitor cell line, DBT, D1A and D3O, three astrocytic cell lines, suggesting that undifferentiated glial cells do not express this receptor subtype. Finally, we found that THC (5 µM) only modestly increased IP3 production in BV2 cells, suggesting that mechanisms in addition to phospholipase C may be involved in GPR55-mediated increases in intracellular calcium. Our data identify GPR55 as a bona fide cannabinoid receptor ...
    Nov 14, 2005
  • Abstract
    Individual responses to novelty reflect differences in sensitivity to cannabinoid administration
    Experimental animals can be differentiated on the basis of their horizontal or vertical activity as high responders (HR) and low responders (LR) upon exposure to a novel environment. These individual differences have been associated with discrete behavi...
    Nov 7, 2007
  • Abstract
    Evidence for dissociable precise and approximate mechanisms of quantifier comprehension
    We demonstrated previously that a class of number words- quantifiers- rely on a cortical network of number processing regions. Our model of quantifier comprehension includes a numerosity component supported by number processing portions of the brain and...
    Nov 7, 2007
  • Previous
  • 47
  • 48
  • 49
  • 50
  • 51
  • Next

Featured

  • SfN Selects Kevin B. Marvel, PhD, as Next Executive Director
  • Read the Neuroscience Quarterly - Fall 2025
  • Renew your SfN Membership Today!
SfN Websites
  • BrainFacts.org logo
  • eNeuro logo
  • JNeurosci logo
  • Neuronline logo
Engage with SfN
  • join Join
  • give Give
  • advocate Advocate
  • publish Publish
Quick Links
  • SfN News
  • For Press
  • Global Events
  • Contact Us
  • Advertise
  • Code of Conduct
  • Jobs at SfN
  • SfN Store
  • Social Media
Follow SfN
  • BlueSky logo
  • Facebook logo
  • Instagram logo
  • LinkedIn logo

  • Threads logo
  • X Logo
  • YouTube logo
SfN logo with "SfN" in a blue box next to Society for Neuroscience in red text and the SfN tag line that reads "Advancing the understanding of the brain and nervous system"
1121 14th Street NW, Suite 1010, Washington, D.C. 20005
(202) 962-4000 | 1-888-985-9246
  • Accessibility Policy
  • Disclaimer
  • Privacy Notice
  • Contact Us

Copyright ©
Society for Neuroscience